Table 2.
Parameter | Research Date | |||
---|---|---|---|---|
Before the Start of the Study (before WBC) | Following WBC | Following Exercise Preceded by WBC (WBC Exercise) | Following Exercise without WBC (Control Exercise) | |
Mean ± SD | ||||
CD in plasma (10−2 Abs./mL) | 8.14 ± 3.25 | 6.6 ± 3.20 | 6.83 ± 3.27 | 7.77 ± 3.13 |
TBARS in erythrocytes (nmol MDA/g Hb) | 42.87 ± 15.69 | 38.7 ± 13.01 | 37.78 ± 12.78 | 40.14 ± 11.15 |
TBARS in plasma (10−2 nmol MDA/mL) | 39.97 ± 15.07 | 38.34 ± 15.04 | 34.37 ± 8.7 | 40.06 ± 8.21 |
LOOH in serum (mol/L) | 188.0 ± 78.89 | 183.0 ± 80.11 | 209.0 ± 81.88 | 227.1 ± 74.54 |
vit. A in plasma (mg/L) | 234.9 ± 83.96 | 224.2 ± 89.09 | 227.5 ± 87.14 | 219.2 ± 83.22 |
vit. E in plasma (mg/L) | 701.5 ± 236.6 | 684.3 ± 263.8 | 678.6 ± 239.6 | 585.6 ± 253.7 |
SOD (U/g Hb) | 1263.0 ± 250.6 | 1315.7 ± 288.8 | 1366.5 ± 273.5 | 1407.0 ± 305.5 |
CAT (104 IU/g Hb) | 52.25 ± 19.53 | 51.87 ± 19.43 | 51.09 ± 20.25 | 67.14 ± 11.6 aa bb ccc |
GPx (U/g Hb) | 3.87 ± 1.62 | 3.81 ± 1.67 | 3.88 ± 1.68 | 4.88 ± 1.58 |
a Statistically significant difference in comparison with the activity measured before WBC (aa p < 0.01); b statistically significant difference in comparison with the activity measured after WBC (bb p < 0.01); c statistically significant difference in comparison with the activity measured after the exercise associated with WBC (ccc p < 0.001).